115 filings
8-K
IXHL
Incannex Healthcare Ltd
30 May 24
Other Events
8:30am
10-Q
2024 Q3
IXHL
Incannex Healthcare Ltd
Quarterly report
15 May 24
1:32pm
8-K
IXHL
Incannex Healthcare Ltd
7 May 24
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
8:30am
8-K
IXHL
Incannex Healthcare Ltd
16 Apr 24
Incannex Healthcare Inc. Quarterly Update, Q1 2024
9:30am
8-K
IXHL
Incannex Healthcare Ltd
5 Mar 24
Departure of Directors or Certain Officers
6:11am
8-K
y93 tnv8r4mxofd6l
28 Feb 24
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
7:42am
8-K
hhw2vkpxev7
16 Feb 24
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
8:00am
10-Q
om0zlt6
14 Feb 24
Quarterly report
6:16am
8-K
jq1g7l
1 Feb 24
Other Events
7:30am
8-K
5ax3dn
24 Jan 24
Other Events
4:30pm
8-K
wndtr
18 Jan 24
Other Events
9:08am
8-K
vfrhsp z8
17 Jan 24
Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
6:05am
8-K
dme 76jtx
22 Dec 23
Clarion Clinics Receives Ethics Board Endorsment for the First Dedicated Psychedelic-assisted Therapy Clinic In Australia
6:07am
S-8
delrj5
20 Dec 23
Registration of securities for employees
5:05pm
8-K
jdodigpr
15 Dec 23
Changes in Registrant's Certifying Accountant
6:09am
EFFECT
lt3nwx
1 Dec 23
Notice of effectiveness
12:15am
8-K
7mquatj6
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
POS AM
rgfif
29 Nov 23
Prospectus update (post-effective amendment)
4:21pm
15-12G
qwnw48og
29 Nov 23
Securities registration termination
4:06pm
25-NSE/A
opi40 gd9o9wh
29 Nov 23
Exchange delisting (amended)
4:06pm